IP6-generated IPPs also have a role in insulin secretion and sensitivity; IP6-kinase 1 has been shown to regulate insulin secretion and signaling, which can be targeted in type 2 diabetes therapy [20]. This evidence concerns the gene INS and type 2 diabetes mellitus.